TENOR CAPITAL MANAGEMENT Co., L.P. - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V116. A total of 14 filers reported holding EFFECTOR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TENOR CAPITAL MANAGEMENT Co., L.P. ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,533
-56.2%
33,3330.0%0.00%
Q2 2023$5,783
+34.3%
33,3330.0%0.00%
Q1 2023$4,307
-21.1%
33,3330.0%0.00%
Q4 2022$5,457
-22.0%
33,3330.0%0.00%
Q3 2022$7,000
-12.5%
33,3330.0%0.00%
Q2 2022$8,000
-42.9%
33,3330.0%0.00%
Q1 2022$14,000
-51.7%
33,3330.0%0.00%
-100.0%
Q4 2021$29,000
-45.3%
33,3330.0%0.00%0.0%
Q3 2021$53,00033,3330.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Evolution Capital Management LLC 50,000$10,0000.02%
ARISTEIA CAPITAL, L.L.C. 1,557,474$264,0000.01%
LITTLEJOHN & CO LLC 16,666$3,0000.00%
MMCAP International Inc. SPC 145,941$30,0000.00%
WHITEBOX ADVISORS LLC 298,145$61,0000.00%
Parallel Advisors, LLC 64,166$13,0000.00%
CVI Holdings, LLC 49,738$10,0000.00%
III Capital Management 41,795$7,0000.00%
Tower Research Capital LLC (TRC) 23$00.00%
Jefferies Group LLC 10,000$2,0340.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders